Article
Specific myeloid signatures in peripheral blood differentiate active and rare clinical phenotypes of multiple sclerosis.
Frontiers in immunology - 1 Jan 2023
Vakrakou Aigli G, Paschalidis Nikolaos, Pavlos Eleftherios, Giannouli Christina, Karathanasis Dimitris, Tsipota Xristina, Velonakis Georgios, Stadelmann-Nessler Christine, Evangelopoulos Maria-Eleftheria, Stefanis Leonidas, Kilidireas Constantinos
Abstract excerpt
Current understanding of Multiple Sclerosis (MS) pathophysiology implicates perturbations in adaptive cellular immune responses, predominantly T cells, in Relapsing-Remitting forms (RRMS). Nevertheless, from a clinical perspective MS is a heterogeneous disease reflecting the heterogeneity of involved biological systems. This complexity requires advanced analysis tools at the single-cell level to discover...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
